The control and manipulation of angiogenesis in the primate corpus luteum
暂无分享,去创建一个
[1] N. Ling,et al. Fibroblast growth factors are present in the extracellular matrix produced by endothelial cells in vitro: implications for a role of heparinase-like enzymes in the neovascular response. , 1987, Biochemical and biophysical research communications.
[2] A. Zeleznik,et al. Progesterone does not inhibit gonadotropin-induced follicular maturation in the female rhesus monkey (Macaca mulatta). , 1980, Endocrinology.
[3] M. Janicek,et al. Tumor angiogenesis as a prognostic factor in ovarian carcinoma , 1997, Cancer.
[4] A. Zeleznik,et al. Ovarian responses in macaques to pulsatile infusion of follicle-stimulating hormone (FSH) and luteinizing hormone: increased sensitivity of the maturing follicle to FSH. , 1986, Endocrinology.
[5] S. Steinberg,et al. Tumor angiogenesis in advanced stage ovarian carcinoma. , 1995, The American journal of pathology.
[6] F. Teasdale. Numerical density of nuclei in the sheep placenta , 1976, The Anatomical record.
[7] J. Strauss,et al. Stimulation of progesterone synthesis in luteinized human granulosa cells by human chorionic gonadotropin and 8-bromo-adenosine 3',5'-monophosphate: the effect of low density lipoprotein. , 1984, The Journal of clinical endocrinology and metabolism.
[8] S. Killilea,et al. Mitogenic factors of corpora lutea. , 1994, Progress in growth factor research.
[9] P. Hornsby,et al. The role of lipid peroxidation and biological antioxidants in the function of the adrenal cortex. Part 1: A background review , 1983, Molecular and Cellular Endocrinology.
[10] D. Baird,et al. Mediation of gonadotrophin‐stimulated growth and differentiation of human granulosa cells by adenosine‐3′,5′‐monophosphate: one molecule, two messages , 1992, Clinical endocrinology.
[11] Pamela F. Jones,et al. Isolation of Angiopoietin-1, a Ligand for the TIE2 Receptor, by Secretion-Trap Expression Cloning , 1996, Cell.
[12] R. Goldenberg,et al. Ovarian morphology in women with anosmia and hypogonadotropic hypogonadism. , 1976, American journal of obstetrics and gynecology.
[13] Sandra R. Smith,et al. An activated form of transforming growth factor beta is produced by cocultures of endothelial cells and pericytes. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[14] J. Flanagan,et al. Heterodimers of Placenta Growth Factor/Vascular Endothelial Growth Factor , 1996, The Journal of Biological Chemistry.
[15] J. Kraehenbuhl,et al. Localization of intracellular antigens by immunoelectron microscopy. , 1974, International review of experimental pathology.
[16] D. Dierschke,et al. Functional luteolysis in the rhesus monkey; the role of estrogen. , 1973, Endocrinology.
[17] H. Fraser,et al. Initiation of high dose gonadotrophin-releasing hormone antagonist treatment during the late follicular phase in the macaque abolishes luteal function irrespective of effects upon the luteinizing hormone surge. , 1997, Human reproduction.
[18] A. Zeleznik,et al. Gonadotropin-binding sites in the rhesus monkey ovary: role of the vasculature in the selective distribution of human chorionic gonadotropin to the preovulatory follicle. , 1981, Endocrinology.
[19] W. Chamley,et al. Changes in small blood vessels during cyclical luteal regression in sheep. , 1977, Biology of reproduction.
[20] H. Tamura,et al. Angiogenesis and its hormonal control in the corpus luteum of the pregnant rat. , 1987, Biology of reproduction.
[21] A. Hirshfield. Continuous [3H] thymidine infusion: a method for the study of follicular dynamics. , 1984, Biology of reproduction.
[22] D. Charnock-Jones,et al. Localization of VEGF and expression of its receptors flt and KDR in human placenta throughout pregnancy. , 1996, Human reproduction.
[23] A. L. Goodman,et al. Regulation of folliculogenesis in the cycling rhesus monkey: selection of the dominant follicle. , 1977, Endocrinology.
[24] H. Fraser,et al. Inhibition of early luteal angiogenesis by gonadotropin-releasing hormone antagonist treatment in the primate. , 2000, The Journal of clinical endocrinology and metabolism.
[25] H. Fraser,et al. GnRH receptor mRNA expression by in-situ hybridization in the primate pituitary and ovary. , 1996, Molecular human reproduction.
[26] D. Redmer,et al. Angiogenesis in the ovary. , 1996, Reviews of reproduction.
[27] D. Baird,et al. Differential regulation of cholesterol side-chain cleavage (P450scc) and aromatase (P450arom) enzyme mRNA expression by gonadotrophins and cyclic AMP in human granulosa cells. , 1994, Journal of molecular endocrinology.
[28] R. Nicosia,et al. Rat aortic smooth muscle cells become pericytes during angiogenesis in vitro. , 1995, Laboratory investigation; a journal of technical methods and pathology.
[29] J. McGeachie,et al. Angiogenesis in the developing corpus luteum of pregnant rats: A stereologic and autoradiographic study , 1988, The Anatomical record.
[30] T J Poole,et al. Vasculogenesis and angiogenesis: two distinct morphogenetic mechanisms establish embryonic vascular pattern. , 1989, The Journal of experimental zoology.
[31] J. Cameron,et al. Gonadotropin receptors of the primate corpus luteum. I. Characterization of 125I-labeled human luteinizing hormone and human chorionic gonadotropin binding to luteal membranes from the rhesus monkey. , 1982, Endocrinology.
[32] F. Gaytán,et al. Proliferative activity in the different ovarian compartments in cycling rats estimated by the 5-bromodeoxyuridine technique. , 1996, Biology of reproduction.
[33] C. Heldin,et al. B-type receptor for platelet-derived growth factor mediates a chemotactic response by means of ligand-induced activation of the receptor protein-tyrosine kinase. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[34] E. Lenton,et al. The endocrinology of conception cycles and implantation in women. , 1988, Journal of reproduction and fertility. Supplement.
[35] S. L. Marcus,et al. Functional activity of the corpus luteum following hysterectomy. , 1970, The Journal of clinical endocrinology and metabolism.
[36] H. Fraser,et al. Luteal regression in the primate: different forms of cell death during naturaland gonadotropin-releasing hormone antagonist or prostaglandin analogue-induced luteolysis. , 1999, Biology of reproduction.
[37] F. Khan-dawood,et al. Expression of gap junction protein connexin-43 in the human and baboon (Papio anubis) corpus luteum. , 1996, The Journal of clinical endocrinology and metabolism.
[38] L. Speroff,et al. Prostaglandin F-2 induced steroidogenesis and luteolysis in the primate corpus luteum. , 1973, The Journal of clinical endocrinology and metabolism.
[39] J. Zheng,et al. Initial characterization of endothelial mitogens produced by bovine corpora lutea from the estrous cycle. , 1993, Biochemistry and cell biology = Biochimie et biologie cellulaire.
[40] J. Tilly. Apoptosis and the ovary: a fashionable trend or food for thought? , 1997, Fertility and sterility.
[41] H. Moukadiri,et al. Characterization of the receptor to vasculotropin on bovine adrenal cortex-derived capillary endothelial cells. , 1990, The Journal of biological chemistry.
[42] D. Gospodarowicz,et al. Characterization of the receptors for vascular endothelial growth factor. , 1990, The Journal of biological chemistry.
[43] R. Stouffer,et al. Isolation and culture of microvascular endothelial cells from the primate corpus luteum. , 1996, Biology of reproduction.
[44] G. Gray,et al. Inhibition of tumor growth in mice by an analogue of platelet factor 4 that lacks affinity for heparin and retains potent angiostatic activity. , 1991, Cancer research.
[45] G. Niswender,et al. Mechanisms of luteolysis in domestic livestock. , 1988, Domestic animal endocrinology.
[46] D. Goeddel,et al. Vascular endothelial growth factor is a secreted angiogenic mitogen. , 1989, Science.
[47] Pamela F. Jones,et al. Requisite Role of Angiopoietin-1, a Ligand for the TIE2 Receptor, during Embryonic Angiogenesis , 1996, Cell.
[48] J. Hodges,et al. Comparison of the luteolytic action of gonadotrophin-releasing hormone antagonist and cloprostenol, and the ability of human chorionic gonadotrophin and melatonin to override their luteolytic effects in the marmoset monkey. , 1991, The Journal of endocrinology.
[49] V. Lenaerts,et al. Antarelix (EP 24332) a novel water soluble LHRH antagonist. , 1993, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[50] H. Granger,et al. Placenta growth factor-1 is chemotactic, mitogenic, and angiogenic. , 1997, Laboratory investigation; a journal of technical methods and pathology.
[51] D. de Ziegler,et al. Role of estradiol in the rise in follicle-stimulating hormone levels during the luteal-follicular transition. , 1993, The Journal of clinical endocrinology and metabolism.
[52] A. Gougeon,et al. Evolution of the diameters of the largest healthy and atretic follicles during the human menstrual cycle. , 1983, Journal of reproduction and fertility.
[53] G. Yancopoulos,et al. Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development. , 1999, Genes & development.
[54] Lars Holmgren,et al. Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression , 1995, Nature Medicine.
[55] J. Winer,et al. Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR. , 1994, The Journal of biological chemistry.
[56] D. Baird,et al. Concentration of oestrogens and androgens in human ovarian venous plasma and follicular fluid throughout the menstrual cycle. , 1976, The Journal of endocrinology.
[57] M. E. Simpson,et al. Postnatal development of the ovary in Homo sapiens and Macaca mulatta, and induction of ovulation in the macaque, , 1973 .
[58] M. Skinner,et al. 3 – Growth Factor-Mediated Cell–Cell Interactions in the Ovary , 1994 .
[59] J. Rossant,et al. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium , 1995, Nature.
[60] A HENRIQUES FURTADO,et al. [Early pregnancy]. , 1947, Revista de ginecologia e d'obstetricia.
[61] F. Khan-dawood,et al. Baboon corpus luteum: presence of oxytocin receptors. , 1993, Biology of reproduction.
[62] S. Fox,et al. Association of tumor angiogenesis with bone marrow micrometastases in breast cancer patients. , 1997, Journal of the National Cancer Institute.
[63] G. Yancopoulos,et al. New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF , 1999, Oncogene.
[64] Kenneth J. Hillan,et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene , 1996, Nature.
[65] J. Cornette,et al. Vascular control of luteal steroidogenesis. , 1970, Journal of reproduction and fertility. Supplement.
[66] J. Juengel,et al. Mechanisms controlling the function and life span of the corpus luteum. , 2000, Physiological reviews.
[67] J. Juengel,et al. Protein kinase C second messenger system mediates the antisteroidogenic effects of prostaglandin F2 alpha in the ovine corpus luteum in vivo. , 1994, Biology of reproduction.
[68] G. Aguilera,et al. Localization of insulin-like growth factor (IGF-I) and IGF-I receptor expression in human corpora lutea: role on estradiol secretion**Supported by FONDECYT 1931041, Santiago, Chile. , 1996 .
[69] L. Espey. Ovulation as an inflammatory reaction--a hypothesis. , 1980, Biology of reproduction.
[70] H. Peters,et al. Follicular growth: the basic event in the mouse and human ovary. , 1975, Journal of reproduction and fertility.
[71] L. Cantley,et al. Vascular Dysmorphogenesis Caused by an Activating Mutation in the Receptor Tyrosine Kinase TIE2 , 1996, Cell.
[72] R. Meidan,et al. Regulation of endothelin-1 expression in the bovine corpus luteum: elevation by prostaglandin F 2 alpha. , 1996, Endocrinology.
[73] N. Dekel,et al. 8 – Molecular Mechanisms in Ovulation , 1994 .
[74] L. Reynolds. Utero-ovarian interactions during early pregnancy: role of conceptus-induced vasodilation. , 1986, Journal of animal science.
[75] A. Gougeon. Dynamics of follicular growth in the human: a model from preliminary results. , 1986, Human reproduction.
[76] Sabita Roy,et al. Targeting the tumor vasculature: Inhibition of tumor growth by a vascular endothelial growth factor‐toxin conjugate , 1997, International journal of cancer.
[77] G. D. Phillips,et al. Vascular endothelial growth factor (rhVEGF165) stimulates direct angiogenesis in the rabbit cornea. , 1994, In vivo.
[78] L. Giudice,et al. Programmed cell death in human ovary is a function of follicle and corpus luteum status. , 1997, The Journal of clinical endocrinology and metabolism.
[79] G. Hodgen,et al. Folliculogenesis in the primate ovarian cycle. , 1981, Endocrine reviews.
[80] K. Hirschi,et al. Endothelial cells modulate the proliferation of mural cell precursors via platelet-derived growth factor-BB and heterotypic cell contact. , 1999, Circulation research.
[81] J. McCRACKEN,et al. Luteolysis: a neuroendocrine-mediated event. , 1999, Physiological reviews.
[82] Dendra M. Hillier,et al. Paracrine Control of Follicular Estrogen Synthesis , 1991 .
[83] James B. Brown,et al. Pituitary Control of Ovarian Function — Concepts Derived from Gonadotrophin Therapy , 1978, The Australian & New Zealand journal of obstetrics & gynaecology.
[84] S. Huang,et al. Application of immunofluorescent staining on paraffin sections improved by trypsin digestion. , 1976, Laboratory investigation; a journal of technical methods and pathology.
[85] P. Chomczyński,et al. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.
[86] D. Darland,et al. Blood vessel maturation: vascular development comes of age. , 1999, The Journal of clinical investigation.
[87] S. Hillier,et al. Cell-specific expression of aromatase and LH receptor mRNAs in rat ovary. , 1992, Journal of molecular endocrinology.
[88] R. Stouffer,et al. Expression of matrix metalloproteinases and their tissue inhibitor messenger ribonucleic acids in macaque periovulatory granulosa cells: time course and steroid regulation. , 1999, Biology of reproduction.
[89] Yasuhiko Hayashi,et al. Possible Participation of Autocrine and Paracrine Vascular Endothelial Growth Factors in Hypoxia-induced Proliferation of Endothelial Cells and Pericytes (*) , 1995, The Journal of Biological Chemistry.
[90] D. Redmer,et al. Angiogenic activity of bovine corpora lutea at several stages of luteal development. , 1988, Journal of reproduction and fertility.
[91] J. Mcgadey. A tetrazolium method for non-specific alkaline phosphatase , 2004, Histochemie.
[92] A. Schor,et al. Tumour angiogenesis , 1983, The Journal of pathology.
[93] R. Bicknell. Endothelial cell culture: Introduction to the endothelial cell , 1996 .
[94] R. Boulton,et al. Assessing cell proliferation: a methodological review. , 1995, Clinical science.
[95] N. Chegini,et al. Quantitative cell composition of human and bovine corpora lutea from various reproductive states. , 1991, Biology of reproduction.
[96] A. R. Midgley,et al. Granulosa cell maturation in the rat: increased binding of human chorionic gonadotropin following treatment with follicle-stimulating hormone in vivo. , 1974, Endocrinology.
[97] L. Hamberger,et al. The Role of Prostaglandins and Catecholamines for Human Corpus Luteum Function , 1987 .
[98] J. Richards. Hormonal control of gene expression in the ovary. , 1994, Endocrine reviews.
[99] H. Phillips,et al. Vascular endothelial growth factor is expressed in rat corpus luteum. , 1990, Endocrinology.
[100] H. Fraser,et al. Suppression of luteal function by a luteinizing hormone-releasing hormone antagonist during the early luteal phase in the stumptailed macaque monkey and the effects of subsequent administration of human chorionic gonadotropin. , 1987, Endocrinology.
[101] The Role of Lipoproteins in the Regulation of Progesterone Secretion by the Human Corpus Luteum , 1982, Fertility and sterility.
[102] David F. Albertini,et al. THE APPEARANCE AND STRUCTURE OF INTERCELLULAR CONNECTIONS DURING THE ONTOGENY OF THE RABBIT OVARIAN FOLLICLE WITH PARTICULAR REFERENCE TO GAP JUNCTIONS , 1974, The Journal of cell biology.
[103] J. Kerr,et al. Patterns of cell death. , 1988, Methods and achievements in experimental pathology.
[104] H. Fraser,et al. Induced luteal regression in the primate: evidence for apoptosis and changes in c-myc protein. , 1995, The Journal of endocrinology.
[105] S. Killilea,et al. Production of mitogenic factor(s) by ovine corpora lutea throughout the estrous cycle. , 1992, Endocrinology.
[106] A. Cummings,et al. Differentiation of the uterus in preparation for gestation: a model for the action of progesterone. , 1984, Journal of theoretical biology.
[107] A. Zeleznik. Premature elevation of systemic estradiol reduces serum levels of follicle-stimulating hormone and lengthens the follicular phase of the menstrual cycle in rhesus monkeys. , 1981, Endocrinology.
[108] K. Hirschi,et al. Pericytes in the microvasculature. , 1996, Cardiovascular research.
[109] J. Tilly,et al. Gonadotropin-induced up- and down-regulation of ovarian follicle-stimulating hormone (FSH) receptor gene expression in immature rats: effects of pregnant mare's serum gonadotropin, human chorionic gonadotropin, and recombinant FSH. , 1992, Endocrinology.
[110] M. Ferin,et al. Mechanisms regulating the menstrual cycle in women. , 1970, Recent progress in hormone research.
[111] A. Ferenczy,et al. Proliferation kinetics of human endometrium during the normal menstrual cycle. , 1979, American journal of obstetrics and gynecology.
[112] E. Adashi,et al. Insulin‐like Growth Factor I as an Intraovarian Regulator: Basic and Clinical Implications a , 1991, Annals of the New York Academy of Sciences.
[113] G. Niswender,et al. Blood flow: a mediator of ovarian function. , 1976, Biology of reproduction.
[114] R. Koos. Stimulation of endothelial cell proliferation by rat granulosa cell-conditioned medium. , 1986, Endocrinology.
[115] M. Sholley,et al. Endothelial mitosis during the initial stages of corpus luteum neovascularization in the cycling adult rat. , 1985, The American journal of anatomy.
[116] H. Fraser,et al. The effect of the angiogenesis inhibitor TNP-470 on luteal establishment and function in the primate. , 1999, Human reproduction.
[117] W. Hansel,et al. Corpus luteum function in the alpaca. , 1970, Biology of reproduction.
[118] L. Speroff,et al. ESTROGEN-INDUCED HUMAN LUTEOLYSIS , 1973 .
[119] H. Dvorak,et al. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. , 1983, Science.
[120] A. Dharmarajan,et al. Quantitative ultrastructural characteristics relating to transport between luteal cell cytoplasm and blood in the corpus luteum of the pregnant rat. , 1985, The American journal of anatomy.
[121] K. Alitalo,et al. VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development. , 1996, Development.
[122] G. Niswender,et al. Nuclear changes in ovine luteal cells in response to PGF2 alpha. , 1990, Domestic animal endocrinology.
[123] D. Baird,et al. Changes in the binding of human chorionic gonadotrophin/luteinizing hormone, follicle-stimulating hormone and prolactin to human corpora lutea during the menstrual cycle and pregnancy. , 1980, The Journal of endocrinology.
[124] M. Klagsbrun,et al. Vascular endothelial growth factor and its receptors. , 1996, Cytokine & growth factor reviews.
[125] U. Modlich,et al. Ovarian angiogenesis. Phenotypic characterization of endothelial cells in a physiological model of blood vessel growth and regression. , 1995, The American journal of pathology.
[126] C. Channing. Influences of the in vivo and in vitro hormonal environment upon luteinization of granulosa cells in tissue culture. , 1970, Recent progress in hormone research.
[127] G. Garcı́a-Cardeña,et al. Direct actions of angiopoietin-1 on human endothelium: evidence for network stabilization, cell survival, and interaction with other angiogenic growth factors. , 1999, Laboratory investigation; a journal of technical methods and pathology.
[128] D. Baird,et al. PHARMACOLOGICAL‘RESCUE’OF THE CORPUS LUTEUM RESULTS IN INCREASED INHIBIN PRODUCTION , 1990, Clinical endocrinology.
[129] B. Charbonnel,et al. Suppression of corpus luteum function by the gonadotropin-releasing hormone antagonist Nal-Glu: effect of the dose and timing of human chorionic gonadotropin administration. , 1991, Fertility and sterility.
[130] S. Liu,et al. Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries. , 1993, The American journal of physiology.
[131] H. R. Lindner,et al. Distribution of binding sites for human chorionic gonadotropin in the preovulatory follicle of the rat , 1975, The Journal of cell biology.
[132] J. Strauss,et al. Progesterone synthesis by luteinized human granulosa cells in culture: the role of de novo sterol synthesis and lipoprotein-carried sterol. , 1982, The Journal of clinical endocrinology and metabolism.
[133] A. Zeleznik,et al. The Rhesus Monkey Corpus Luteum Is Dependent on Pituitary Gonadotropin Secretion throughout the Luteal Phase of the Menstrual Cycle , 1984 .
[134] M. J. Koering. Cyclic changes in ovarian morphology during the menstrual cycle in Macaca mulatta. , 1969, The American journal of anatomy.
[135] C. Belfiore,et al. Steroidogenic enzyme activity after acute activation of protein kinase (PK) A and PKC in ovine small and large luteal cells , 1993, Molecular and Cellular Endocrinology.
[136] L. Orci,et al. Alpha-smooth muscle actin, a differentiation marker of smooth muscle cells, is present in microfilamentous bundles of pericytes. , 1989, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[137] A. Rogol,et al. Role of steroidogenic acute regulatory protein in adrenal and gonadal steroidogenesis. , 1995, Science.
[138] L. Wildt,et al. Pregnancies following chronic intermittent (pulsatile) administration of Gn-RH by means of a portable pump ("Zyklomat")--a new approach to the treatment of infertility in hypothalamic amenorrhea. , 1980, The Journal of clinical endocrinology and metabolism.
[139] P. Rogers,et al. Endometrial microvascular growth in normal and dysfunctional states. , 1998, Human reproduction update.
[140] D. Haisenleder,et al. Gonadotropin-releasing hormone pulses: regulators of gonadotropin synthesis and ovulatory cycles. , 1991, Recent progress in hormone research.
[141] Mihaela Skobe,et al. Halting angiogenesis suppresses carcinoma cell invasion , 1997, Nature Medicine.
[142] R. Engerman,et al. Cell turnover of capillaries. , 1967, Laboratory investigation; a journal of technical methods and pathology.
[143] D. Ingber,et al. Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth , 1990, Nature.
[144] H. Augustin,et al. Analysis of blood vessel maturation processes during cyclic ovarian angiogenesis. , 1998, Laboratory investigation; a journal of technical methods and pathology.
[145] J. Davies,et al. The vascular system of the rabbit ovary and its relationship to ovulation , 1951, The Anatomical record.
[146] P. Einat,et al. Translation of Vascular Endothelial Growth Factor mRNA by Internal Ribosome Entry: Implications for Translation under Hypoxia , 1998, Molecular and Cellular Biology.
[147] W. C. Duncan,et al. The human corpus luteum: reduction in macrophages during simulated maternal recognition of pregnancy. , 1998, Human reproduction.
[148] E. Keshet,et al. A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. , 1998, Development.
[149] A. L. Goodman,et al. The ovarian triad of the primate menstrual cycle. , 1983, Recent progress in hormone research.
[150] B. Burnside,et al. Actin filaments in retinal pericytes and endothelial cells. , 1980, Investigative ophthalmology & visual science.
[151] R. Stouffer,et al. Vascular endothelial growth factor (VEGF) and angiopoietin regulation by gonadotrophin and steroids in macaque granulosa cells during the peri-ovulatory interval. , 1999, Molecular human reproduction.
[152] C. Channing,et al. Fine structural events correlated with progestin secretion during luteinization of rhesus monkey granulosa cells in culture. , 1972, Biology of reproduction.
[153] Y. Hirata,et al. Molecular cloning of a novel vascular endothelial growth factor, VEGF-D. , 1997, Genomics.
[154] C. Hartman,et al. Removal of the corpus luteum and of the ovaries of the rhesus monkey during pregnancy: Observations and cautions , 1947, The Anatomical record.
[155] J. Hearn,et al. Changing responsiveness of luteal cells of the marmoset monkey (Callithrix jacchus) to luteotrophic and luteolytic agents during normal and conception cycles. , 1989, Journal of reproduction and fertility.
[156] R. Kendall,et al. Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[157] E. Reed,et al. The Pharmacokinetics of TNP‐470, a New Angiogenesis Inhibitor , 1997, Pharmacotherapy.
[158] D. Wolf,et al. Administration of human luteinizing hormone (hLH) to macaques after follicular development: further titration of LH surge requirements for ovulatory changes in primate follicles. , 1992, The Journal of clinical endocrinology and metabolism.
[159] Thomas N. Sato,et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. , 1997, Science.
[160] H. Dvorak,et al. Secretion of vascular endothelial growth factor/vascular permeability factor from human luteinized granulosa cells is human chorionic gonadotrophin dependent. , 1998, Molecular human reproduction.
[161] J. Hearn,et al. Size distribution of luteal cells from pregnant and non-pregnant marmoset monkeys and a comparison of the morphology of marmoset luteal cells with those from the human corpus luteum. , 1990, Journal of reproduction and fertility.
[162] Yvi J. Lebeux,et al. Actin‐ and myosin‐like filaments in rat brain pericytes , 1978, The Anatomical record.
[163] S. Lightman,et al. Induction of luteal regression in the marmoset monkey (Callithrix jacchus) by a gonadotrophin-releasing hormone antagonist and the effects on subsequent follicular development. , 1988, Journal of reproduction and fertility.
[164] H. Dvorak,et al. Vascular permeability factor/vascular endothelial growth factor: a multifunctional angiogenic cytokine. , 1997, EXS.
[165] L. Orci,et al. Basic fibroblast growth factor induces angiogenesis in vitro. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[166] R. Stouffer,et al. Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1997 by The Endocrine Society Follicle-Stimulating Hormone and Luteinizing Hormone/ Chorionic Gonadotropin Stimulation of Vascular Endothelial Growth Factor Production by Macaq , 2022 .
[167] H. Behrman,et al. Oxygen Radicals and Reactive Oxygen Species in Reproduction , 1991, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[168] J. Finlayson,et al. Regulation of fibronectin and laminin synthesis by retinal capillary endothelial cells and pericytes in vitro. , 1993, Experimental eye research.
[169] Lars Holmgren,et al. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma , 1994, Cell.
[170] H. Yamamoto,et al. Vascular pericytes not only regulate growth, but also preserve prostacyclin-producing ability and protect against lipid peroxide-induced injury of co-cultured endothelial cells. , 1993, Biochemical and biophysical research communications.
[171] R. Ohlsson,et al. Angiogenesis during human extraembryonic development involves the spatiotemporal control of PDGF ligand and receptor gene expression. , 1991, Development.
[172] A. Gougeon. Regulation of ovarian follicular development in primates: facts and hypotheses. , 1996, Endocrine reviews.
[173] A. Miyamoto,et al. Real-time relationships between intraluteal and plasma concentrations of endothelin, oxytocin, and progesterone during prostaglandin F2alpha-induced luteolysis in the cow. , 1998, Biology of reproduction.
[174] C. Verschraegen,et al. A phase I study of TNP-470 administered to patients with advanced squamous cell cancer of the cervix. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.
[175] W. Pardridge,et al. Differential expression of alpha-actin mRNA and immunoreactive protein in brain microvascular pericytes and smooth muscle cells. , 1994, Journal of neuroscience research.
[176] E. Manseau,et al. Expression of vascular permeability factor/vascular endothelial growth factor by human granulosa and theca lutein cells. Role in corpus luteum development. , 1995, American Journal of Pathology.
[177] Bing Li,et al. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo , 1993, Nature.
[178] J. Williams,et al. Heparin-binding fragments of fibronectin are potent inhibitors of endothelial cell growth. , 1985, The American journal of pathology.
[179] N. Yamanaka,et al. Neovascularization of the corpus luteum of rats during the estrus cycle , 1996, Pathology international.
[180] G. Webley,et al. Roles of cyclic AMP and inositol phosphates in the luteolytic action of cloprostenol, a prostaglandin F2 alpha analogue, in marmoset monkeys (Callithrix jacchus). , 1993, Journal of reproduction and fertility.
[181] S. Wiegand,et al. Luteal angiogenesis: prevention and intervention by treatment with vascular endothelial growth factor trap(A40). , 2001, The Journal of clinical endocrinology and metabolism.
[182] S. Shapiro,et al. Progesterone-altered secretory proteins from cultured human endometrium. , 1983, Endocrinology.
[183] H. Fraser,et al. Insulin-like growth factor binding protein-3 mRNA expression in endothelial cells of the primate corpus luteum. , 1998, Human reproduction.
[184] H. Phillips,et al. Vascular endothelial growth factor messenger ribonucleic acid expression in the primate ovary. , 1992, Endocrinology.
[185] G. Rune,et al. Oxytocin gene expression and oxytocin immunoactivity in the ovary of the common marmoset monkey (Callithrix jacchus). , 1994, Biology of reproduction.
[186] L Piana,et al. CD31 quantitative immunocytochemical assays in breast carcinomas. Correlation with current prognostic factors. , 1995, American journal of clinical pathology.
[187] M. Breckwoldt,et al. Vascular endothelial growth factor (VEGF) messenger ribonucleic acid (mRNA) expression in luteinized human granulosa cells in vitro. , 1993, The Journal of clinical endocrinology and metabolism.
[188] Kenneth J. Hillan,et al. Vascular endothelial growth factor is essential for corpus luteum angiogenesis , 1998, Nature Medicine.
[189] R. Stouffer,et al. Proliferation of microvascular endothelial cells in the primate corpus luteum during the menstrual cycle and simulated early pregnancy. , 1996, Endocrinology.
[190] D. Redmer,et al. Angiogenesis in the corpus luteum , 2000, Endocrine.
[191] D. Gospodarowicz,et al. Production a corpus luteum angiogenic factor responsible for proliferation of capillaries and neovascularization of the corpus luteum. , 1978, Proceedings of the National Academy of Sciences of the United States of America.
[192] D. Baird,et al. Relationship between the secretion of the corpus luteum and the length of the follicular phase of the ovarian cycle. , 1975, Journal of reproduction and fertility.
[193] D. Redmer,et al. Cellular Interactions in the Corpus Luteum , 1997, Seminars in reproductive endocrinology.
[194] R. Ansbacher,et al. Decidual prolactin production by organ cultures of human endometrium: effects of continuous and intermittent progesterone treatment. , 1986, Biology of reproduction.
[195] A. Hertig,et al. Studies on the human corpus luteum. I. Observations on the ultrastructure of development and regression of the luteal cells during the menstrual cycle. , 1969, The Journal of cell biology.
[196] J. V. Von Roenn,et al. Fumagillin analog in the treatment of Kaposi's sarcoma: a phase I AIDS Clinical Trial Group study. AIDS Clinical Trial Group No. 215 Team. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[197] J. Folkman,et al. Blood Vessel Formation: What Is Its Molecular Basis? , 1996, Cell.
[198] D E Ingber,et al. Mechanochemical switching between growth and differentiation during fibroblast growth factor-stimulated angiogenesis in vitro: role of extracellular matrix , 1989, The Journal of cell biology.
[199] H. Fraser,et al. Induced luteolysis in the primate: rapid loss of luteinizing hormone receptors. , 1998, Human reproduction.
[200] H. Spies,et al. Changing frequency of pulsatile luteinizing hormone and progesterone secretion during the luteal phase of the menstrual cycle of rhesus monkeys. , 1984, Biology of reproduction.
[201] G. de Sousa,et al. Interspecies variability of TNP-470 metabolism, using primary monkey, rat, and dog cultured hepatocytes. , 1997, Drug metabolism and disposition: the biological fate of chemicals.
[202] R. Greep,et al. Effect of HCG antiserum on ovulation and corpus luteum formation in the monkey (Macaca fascicularis). , 1971, The Journal of clinical endocrinology and metabolism.
[203] D E Ingber,et al. Fibronectin controls capillary endothelial cell growth by modulating cell shape. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[204] H. Fraser,et al. Inhibin secretion during the ovulatory cycle and pregnancy in the common marmoset monkey. , 1990, The Journal of endocrinology.
[205] D. Tenen,et al. Molecular cloning of a cDNA encoding CD34, a sialomucin of human hematopoietic stem cells. , 1992, Journal of immunology.
[206] D. Robertson,et al. Plasma inhibin levels during gonadotropin‐induced ovarian hyperstimulation for IVF: A new index of follicular function? , 1987 .
[207] Urban Deutsch,et al. Angiopoietin-1 induces sprouting angiogenesis in vitro , 1998, Current Biology.
[208] P. Bohlen,et al. Corpus luteum angiogenic factor is related to fibroblast growth factor. , 1985, Endocrinology.
[209] W. Risau. Embryonic angiogenesis factors. , 1991, Pharmacology & therapeutics.
[210] I. Rothchild. The regulation of the mammalian corpus luteum. , 1981, Recent progress in hormone research.
[211] R. Nakano,et al. The vascular endothelial growth factor/fms-like tyrosine kinase system in human ovary during the menstrual cycle and early pregnancy. , 1999, The Journal of clinical endocrinology and metabolism.
[212] G. T. Moore,et al. Ovarian function of hysterectomized Macaca fascicularis. , 1979, Biology of reproduction.
[213] C. Zaloudek,et al. Vascular endothelial growth factor localization in human ovary and fallopian tubes: possible role in reproductive function and ovarian cyst formation. , 1996, The Journal of clinical endocrinology and metabolism.
[214] T. Fan,et al. Controlling the vasculature: angiogenesis, anti-angiogenesis and vascular targeting of gene therapy. , 1995, Trends in pharmacological sciences.
[215] S. Pories,et al. An intra-corpus luteum site for the luteolytic action of prostaglandin F2α in the rhesus monkey , 1984 .
[216] B. Murphy,et al. Steroidogenic acute regulatory protein in bovine corpora lutea. , 1996, Biology of reproduction.
[217] R. Miller,et al. The structure and specificity of endothelin receptors: their importance in physiology and medicine. , 1993, Pharmacology & therapeutics.
[218] D. Torry,et al. Angiogenesis and the Expression of Vascular Endothelial Growth Factor in Endometrium and Placenta , 1997, American journal of reproductive immunology.
[219] Shay Soker,et al. Neuropilin-1 Is Expressed by Endothelial and Tumor Cells as an Isoform-Specific Receptor for Vascular Endothelial Growth Factor , 1998, Cell.
[220] W. Thompson,et al. The clinical manipulation of angiogenesis: pathology, side‐effects, surprises, and opportunities with novel human therapies , 1999, The Journal of pathology.
[221] H. Fraser,et al. Endothelial cell proliferation follows the mid-cycle luteinizing hormone surge, but not human chorionic gonadotrophin rescue, in the human corpus luteum. , 1997, Human reproduction.
[222] H. McClure,et al. Pharmacokinetics and metabolism of O-(chloroacetyl-carbamoyl) fumagillol (TNP-470, AGM-1470) in rhesus monkeys , 1996, Cancer Chemotherapy and Pharmacology.
[223] P. Nelson,et al. Effects of different gonadotropin pulse frequencies on corpus luteum function during the menstrual cycle of rhesus monkeys. , 1986, Endocrinology.
[224] A. Csapo,et al. Effects of luteectomy and progesterone replacement therapy in early pregnant patients. , 1973, American journal of obstetrics and gynecology.
[225] D. L. Bassett. The changes in the vascular pattern of the ovary of the albino rat during the estrous cycle , 1943 .
[226] K. Alitalo,et al. A novel vascular endothelial growth factor, VEGF‐C, is a ligand for the Flt4 (VEGFR‐3) and KDR (VEGFR‐2) receptor tyrosine kinases. , 1996, The EMBO journal.
[227] S. Kholkute. Plasma progesterone levels throughout the ovarian cycle of the common marmoset (Callithrix jacchus) , 2006, Primates.
[228] Azmi Ti,et al. Mechanism of deletion of endothelial cells during regression of the corpus luteum. , 1984, Laboratory investigation; a journal of technical methods and pathology.
[229] G. Erickson. Defining Apoptosis: Players and Systems , 1997, The Journal of the Society for Gynecologic Investigation: JSGI.
[230] R. Abdul-Karim,et al. Blood flow to the ovary and corpus luteum at different stages of gestation in the rabbit. , 1973, Fertility and sterility.
[231] S. Hillier,et al. Control of preovulatory follicular estrogen biosynthesis in the human ovary. , 1981, The Journal of clinical endocrinology and metabolism.
[232] D. Redmer,et al. Expression of the angiogenic factors, basic fibroblast growth factor and vascular endothelial growth factor, in the ovary. , 1998, Journal of animal science.
[233] J. D. Neill,et al. Failure of hysterectomy to influence the normal pattern of cyclic progesterone secretion in the rhesus monkey. , 1969, Endocrinology.
[234] D. Hanahan,et al. Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis , 1996, Cell.
[235] H. Fraser,et al. Cell proliferation and vascular morphology in the marmoset corpus luteum. , 2000, Human reproduction.
[236] P. Jones,et al. Prostaglandin F2α activates protein kinase C in human ovarian cells , 1993, Molecular and Cellular Endocrinology.
[237] C. Reymundo,et al. Macrophages, cell proliferation, and cell death in the human menstrual corpus luteum. , 1998, Biology of reproduction.
[238] Janet Rossant,et al. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice , 1995, Nature.
[239] A. Flint,et al. Mechanisms controlling corpus luteum function in sheep, cows, nonhuman primates, and women especially in relation to the time of luteolysis. , 1988, Endocrine reviews.
[240] Hiroshi Yamamoto,et al. Vascular endothelial growth factor acts as a pericyte mitogen under hypoxic conditions. , 1999, Laboratory investigation; a journal of technical methods and pathology.
[241] M. Brown,et al. A receptor-mediated pathway for cholesterol homeostasis. , 1986, Science.
[242] E. Block. Quantitative morphological investigations of the follicular system in women; variations in the different phases of the sexual cycle. , 1951, Acta endocrinologica.
[243] K. Alitalo,et al. Genomic Organization of the Mouse and Human Genes for Vascular Endothelial Growth Factor B (VEGF-B) and Characterization of a Second Splice Isoform* , 1996, The Journal of Biological Chemistry.
[244] A. Mcneilly,et al. Effects of an LH-releasing hormone antagonist on the secretion of LH, FSH, prolactin and ovarian steroids at different stages of the luteal phase in the stumptailed macaque (Macaca arctoides). , 1986, Journal of Endocrinology.
[245] D. D. Bois,et al. A height-weight formula to estimate the surface area of man , 1916 .
[246] J. Martial,et al. The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis. , 1993, Endocrinology.
[247] R. Koistinen,et al. Insulin-like growth factor-I (IGF-I) inhibits production of IGF-binding protein-1 while stimulating estradiol secretion in granulosa cells from normal and polycystic human ovaries. , 1993, The Journal of clinical endocrinology and metabolism.
[248] M. Klagsbrun,et al. Regulators of angiogenesis. , 1991, Annual review of physiology.
[249] J. Folkman,et al. Analysis of experimental antiangiogenic therapy. , 1993, Journal of pediatric surgery.
[250] S. Akiba,et al. Angiogenesis as an unfavorable prognostic factor in human colorectal carcinoma , 1996, Cancer.
[251] J. Carlson,et al. Oxygen radicals and the control of ovarian corpus luteum function. , 1993, Free radical biology & medicine.
[252] A. Jablonka-Shariff,et al. Growth and cellular proliferation of ovine corpora lutea throughout the estrous cycle. , 1993, Endocrinology.
[253] V Nehls,et al. Heterogeneity of microvascular pericytes for smooth muscle type alpha- actin , 1991, The Journal of cell biology.
[254] P. Fricke,et al. Evaluation of growth, cell proliferation, and cell death in bovine corpora lutea throughout the estrous cycle. , 1994, Biology of reproduction.
[255] J. Folkman,et al. The sequence of events in the regression of corneal capillaries. , 1978, Laboratory investigation; a journal of technical methods and pathology.
[256] J. Isner,et al. Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization. , 1998, Circulation research.
[257] R. D'Amato,et al. Critical components of the female reproductive pathway are suppressed by the angiogenesis inhibitor AGM-1470 , 1997, Nature Medicine.
[258] J. Hodges,et al. Cloprostenol-induced luteolysis in the marmoset monkey (Callithrix jacchus). , 1985, Journal of reproduction and fertility.
[259] W L Miller,et al. Molecular biology of steroid hormone synthesis. , 1988, Endocrine reviews.
[260] H. Fraser,et al. Printed in U.S.A. Copyright © 2000 by The Endocrine Society Suppression of Luteal Angiogenesis in the Primate after Neutralization of Vascular Endothelial Growth Factor* , 2022 .
[261] S. Hillier,et al. Follicular oestrogen synthesis: the ‘two-cell, two-gonadotrophin’ model revisited , 1994, Molecular and Cellular Endocrinology.
[262] J. Rhodin,et al. Capillary growth in the mesentery of normal young rats. Intravital video and electron microscope analyses. , 1989, Journal of submicroscopic cytology and pathology.
[263] P. Wright,et al. Cellular composition of the sheep corpus luteum in the mid- and late luteal phases of the oestrous cycle. , 1986, Journal of reproduction and fertility.
[264] C. Ferrell. Placental Regulation of Fetal Growth , 1989 .
[265] Growth factor effects on cells of the vascular wall: a survey. , 1993, Growth factors.
[266] A. Zeleznik,et al. Expression of messenger ribonucleic acids that encode for 3 beta-hydroxysteroid dehydrogenase and cholesterol side-chain cleavage enzyme throughout the luteal phase of the macaque menstrual cycle. , 1991, The Journal of clinical endocrinology and metabolism.
[267] B. Fisch,et al. Cellular basis of luteal steroidogenesis in the human ovary. , 1989, The Journal of endocrinology.
[268] D. Baird,et al. Effect of enucleation of the corpus luteum at different stages of the luteal phase of the human menstrual cycle on subsequent follicular development. , 1984, Journal of reproduction and fertility.
[269] R. Greep,et al. Production of ovulation in the hypophysectomized rhesus monkey. , 1960, Endocrinology.
[270] L. Wildt,et al. Control of the rhesus monkey menstrual cycle: permissive role of hypothalamic gonadotropin-releasing hormone , 1980, Science.
[271] A. Wyllie,et al. Apoptosis: A Basic Biological Phenomenon with Wide-ranging Implications in Tissue Kinetics , 1972, British Journal of Cancer.
[272] T. Jacks,et al. Cell proliferation, DNA repair, and p53 function are not required for programmed death of prostatic glandular cells induced by androgen ablation. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[273] D. Redmer,et al. Utero-placental vascular development and placental function. , 1995, Journal of animal science.
[274] R. Nakano,et al. Apoptosis of human corpora lutea during cyclic luteal regression and early pregnancy. , 1996, The Journal of clinical endocrinology and metabolism.
[275] J. Hearn. Reproduction in new world primates : new models in medical science , 1983 .
[276] D. Abbott,et al. Morphological changes of the ovary and hormonal changes through the ovarian cycle of the common marmoset (Callithrix jacchus) , 1996, Primates.
[277] W. Gradishar. Endpoints for Determination of Efficacy of Antiangiogenic Agents in Clinical Trials , 1999 .
[278] H Stein,et al. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. , 1984, Journal of immunology.
[279] H. Fraser,et al. Cell death during luteal regression in the marmoset monkey (Callithrix jacchus). , 1997, Journal of reproduction and fertility.
[280] M. F. Smith,et al. Effect of prostaglandin F2 alpha on the adenylate cyclase and phosphodiesterase activity of ovine corpora lutea. , 1984, Journal of animal science.
[281] E. Adashi,et al. Ovarian follicular atresia as an apoptotic process: A paradigm for programmed cell death in endocrine tissues , 1992, Molecular and Cellular Endocrinology.